- Home
- POLA vs PSTV Comparison
POLA vs PSTV Comparison
Compare POLA & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- PSTV
- Stock Information
- Founded
- POLA 1979
- PSTV 1996
- Country
- POLA United States
- PSTV United States
- Employees
- POLA N/A
- PSTV N/A
- Industry
- POLA Industrial Machinery/Components
- PSTV Medical/Dental Instruments
- Sector
- POLA Miscellaneous
- PSTV Health Care
- Exchange
- POLA Nasdaq
- PSTV Nasdaq
- Market Cap
- POLA 4.3M
- PSTV 10.4M
- IPO Year
- POLA 2016
- PSTV N/A
- Fundamental
- Price
- POLA $1.90
- PSTV $0.32
- Analyst Decision
- POLA
- PSTV Strong Buy
- Analyst Count
- POLA 0
- PSTV 3
- Target Price
- POLA N/A
- PSTV $10.83
- AVG Volume (30 Days)
- POLA 282.1K
- PSTV 65.6M
- Earning Date
- POLA 08-13-2025
- PSTV 08-13-2025
- Dividend Yield
- POLA N/A
- PSTV N/A
- EPS Growth
- POLA N/A
- PSTV N/A
- EPS
- POLA N/A
- PSTV N/A
- Revenue
- POLA $13,918,000.00
- PSTV $5,206,000.00
- Revenue This Year
- POLA N/A
- PSTV $14.10
- Revenue Next Year
- POLA N/A
- PSTV $7.96
- P/E Ratio
- POLA N/A
- PSTV N/A
- Revenue Growth
- POLA 8.08
- PSTV N/A
- 52 Week Low
- POLA $1.53
- PSTV $0.16
- 52 Week High
- POLA $4.69
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- POLA 57.49
- PSTV 47.13
- Support Level
- POLA $1.81
- PSTV $0.27
- Resistance Level
- POLA $1.97
- PSTV $0.37
- Average True Range (ATR)
- POLA 0.17
- PSTV 0.05
- MACD
- POLA 0.02
- PSTV 0.01
- Stochastic Oscillator
- POLA 29.92
- PSTV 27.65
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).